Vyome Partners With Impetis, a TATA Enterprise, to In‑License Next‑Generation JAK Inhibitors, Unlocking a ~$57B Global Market Opportunity Vyome has…
Vyome Partners With Impetis, a TATA Enterprise, to In‑License Next‑Generation JAK Inhibitors, Unlocking a ~$57B Global Market Opportunity Vyome has…
Executive Orders That Redefine Trade Boundaries US President Donald Trump has signed sweeping executive orders imposing 100% tariffs on patented…
Donald Trump’s return to power in 2026 has reignited the old paradox: adored by his loyalists, distrusted by the majority.…